<?xml version="1.0" encoding="UTF-8"?><xmi:XMI xmlns:tcas="http:///uima/tcas.ecore" xmlns:xmi="http://www.omg.org/XMI" xmlns:cas="http:///uima/cas.ecore" xmlns:types="http:///fr/inra/maiage/bibliome/alvisnlp/bibliomefactory/modules/uima/types.ecore" xmi:version="2.0">
    <cas:NULL xmi:id="0"/>
    <tcas:DocumentAnnotation xmi:id="8" sofa="1" begin="0" end="1529" language="x-unspecified"/>
    <types:DocumentProxy xmi:id="13" sofa="1" id="BB-cat+ner-23704121" features="18" sections="24"/>
    <cas:Sofa xmi:id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="Is fidaxomicin worth the cost? An economic analysis.&#10;In May 2011, the Food and Drug Administration approved fidaxomicin for the treatment of Clostridium difficile infection (CDI). It has been found to be noninferior to vancomycin; however, its cost-effectiveness for the treatment of CDI remains undetermined.&#10;We developed a decision analytic simulation model to determine the economic value of fidaxomicin for CDI treatment from the third-party payer perspective. We looked at CDI treatment in these 3 cases: (1) no fidaxomicin, (2) only fidaxomicin, and (3) fidaxomicin based on strain typing results.&#10;The incremental cost-effectiveness ratio for fidaxomicin based on screening given current conditions was &gt;$43.7 million per quality-adjusted life-year and using only fidaxomicin was dominated (ie, more costly and less effective) by the other 2 treatment strategies explored. The fidaxomicin strategy tended to remain dominated, even at lower costs. With approximately 50% of CDI due to the NAP1/BI/027 strain, a course of fidaxomicin would need to cost â‰¤$150 to be cost-effective in the treatment of all CDI cases and between $160 and $400 to be cost-effective for those with a non-NAP1/BI/027 strain (ie, treatment based on strain typing).&#10;Given the current cost and NAP1/BI/027 accounting for approximately 50% of isolates, using fidaxomicin as a first-line treatment for CDI is not cost-effective. However, typing and treatment with fidaxomicin based on strain may be more promising depending on the costs of fidaxomicin.&#10;"/>
    <types:FeatureProxy xmi:id="18" key="set" value="train"/>
    <types:SectionProxy xmi:id="24" sofa="1" begin="0" end="1529" name="text" features="" layers="62 79 93" relations="105 178 210 238"/>
    <types:LayerProxy xmi:id="62" sofa="1" name="Paragraph" annotations="66"/>
    <cas:FSArray xmi:id="66" elements="34 41 48 55"/>
    <types:AnnotationProxy xmi:id="34" sofa="1" begin="53" end="309" features=""/>
    <types:AnnotationProxy xmi:id="41" sofa="1" begin="310" end="603" features=""/>
    <types:AnnotationProxy xmi:id="48" sofa="1" begin="604" end="1244" features=""/>
    <types:AnnotationProxy xmi:id="55" sofa="1" begin="1245" end="1528" features=""/>
    <types:LayerProxy xmi:id="79" sofa="1" name="Bacteria" annotations="83"/>
    <cas:FSArray xmi:id="83" elements="72"/>
    <types:AnnotationProxy xmi:id="72" sofa="1" begin="141" end="162" features=""/>
    <types:LayerProxy xmi:id="93" sofa="1" name="Title" annotations="97"/>
    <cas:FSArray xmi:id="97" elements="86"/>
    <types:AnnotationProxy xmi:id="86" sofa="1" begin="0" end="52" features=""/>
    <types:RelationProxy xmi:id="105" sofa="1" features="110" tuples="116 130 144 158" name="Paragraph"/>
    <types:FeatureProxy xmi:id="110" key="kind" value="text"/>
    <types:TupleProxy xmi:id="116" sofa="1" features="120 123" arguments="250"/>
    <types:FeatureProxy xmi:id="120" key="id" value="T4"/>
    <types:FeatureProxy xmi:id="123" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="250" elements="247"/>
    <types:ArgumentProxy xmi:id="247" role="frag0" argument="48"/>
    <types:TupleProxy xmi:id="130" sofa="1" features="134 137" arguments="256"/>
    <types:FeatureProxy xmi:id="134" key="id" value="T5"/>
    <types:FeatureProxy xmi:id="137" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="256" elements="253"/>
    <types:ArgumentProxy xmi:id="253" role="frag0" argument="55"/>
    <types:TupleProxy xmi:id="144" sofa="1" features="148 151" arguments="262"/>
    <types:FeatureProxy xmi:id="148" key="id" value="T2"/>
    <types:FeatureProxy xmi:id="151" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="262" elements="259"/>
    <types:ArgumentProxy xmi:id="259" role="frag0" argument="34"/>
    <types:TupleProxy xmi:id="158" sofa="1" features="162 165" arguments="268"/>
    <types:FeatureProxy xmi:id="162" key="id" value="T3"/>
    <types:FeatureProxy xmi:id="165" key="type" value="Paragraph"/>
    <cas:FSArray xmi:id="268" elements="265"/>
    <types:ArgumentProxy xmi:id="265" role="frag0" argument="41"/>
    <types:RelationProxy xmi:id="178" sofa="1" features="183" tuples="189" name="Bacteria"/>
    <types:FeatureProxy xmi:id="183" key="kind" value="text"/>
    <types:TupleProxy xmi:id="189" sofa="1" features="193 196 199" arguments="274"/>
    <types:FeatureProxy xmi:id="193" key="id" value="T6"/>
    <types:FeatureProxy xmi:id="196" key="type" value="Bacteria"/>
    <types:FeatureProxy xmi:id="199" key="NCBI_Taxonomy" value="1496"/>
    <cas:FSArray xmi:id="274" elements="271"/>
    <types:ArgumentProxy xmi:id="271" role="frag0" argument="72"/>
    <types:RelationProxy xmi:id="210" sofa="1" features="215" tuples="221" name="Title"/>
    <types:FeatureProxy xmi:id="215" key="kind" value="text"/>
    <types:TupleProxy xmi:id="221" sofa="1" features="225 228" arguments="280"/>
    <types:FeatureProxy xmi:id="225" key="id" value="T1"/>
    <types:FeatureProxy xmi:id="228" key="type" value="Title"/>
    <cas:FSArray xmi:id="280" elements="277"/>
    <types:ArgumentProxy xmi:id="277" role="frag0" argument="86"/>
    <types:RelationProxy xmi:id="238" sofa="1" features="" tuples="" name="equiv"/>
    <cas:View sofa="1" members="8 13"/>
</xmi:XMI>
